Concerns over functional experiments, interpretation, and required controls.
作者信息
Wang Eddie Cy, Fielding Ceri A, Stanton Richard J
出版信息
J Clin Invest. 2022 Mar 1;132(5). doi: 10.1172/JCI157369.
Abstract
摘要
相似文献
1
Concerns over functional experiments, interpretation, and required controls.对功能实验、解释及所需对照的担忧。
J Clin Invest. 2022 Mar 1;132(5). doi: 10.1172/JCI157369.
2
Concerns over functional experiments, interpretation, and required controls. Reply.对功能实验、解释及所需对照的担忧。回复。
J Clin Invest. 2022 Mar 1;132(5). doi: 10.1172/JCI158155.
3
Diagnostic Value of Natural Killer Cells, CD56+ CD16+ Natural Killer Cells, , and Lactate Dehydrogenase in Severe/Critical COVID-19: A Prospective Longitudinal Study According to the Severe/Critical COVID-19 Definitions.严重/危重新冠肺炎患者自然杀伤细胞、CD56+CD16+自然杀伤细胞、 和乳酸脱氢酶的诊断价值：根据严重/危重新冠肺炎定义的前瞻性纵向研究。
Viral Immunol. 2022 Nov;35(9):616-628. doi: 10.1089/vim.2022.0060. Epub 2022 Sep 13.
4
Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.Siglec-9 抑制针对 SARS-CoV-2 的抗体依赖的自然杀伤细胞细胞毒性。
mBio. 2023 Feb 28;14(1):e0339322. doi: 10.1128/mbio.03393-22. Epub 2023 Feb 2.
5
Identification of natural killer markers associated with fatal outcome in COVID-19 patients.鉴定与 COVID-19 患者死亡结局相关的自然杀伤细胞标志物。
Front Cell Infect Microbiol. 2023 Jun 5;13:1165756. doi: 10.3389/fcimb.2023.1165756. eCollection 2023.
6
Defining the role of natural killer cells in COVID-19.定义自然杀伤细胞在 COVID-19 中的作用。
Nat Immunol. 2023 Oct;24(10):1628-1638. doi: 10.1038/s41590-023-01560-8. Epub 2023 Jul 17.
7
Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19.重症 COVID-19 患者自然杀伤细胞计数和细胞溶解活性受损。
Blood Adv. 2020 Oct 27;4(20):5035-5039. doi: 10.1182/bloodadvances.2020002650.
8
[Research progress of natural killer (NK) cells and the development of coronavirus disease 2019 (COVID-19)].[自然杀伤（NK）细胞的研究进展与2019冠状病毒病（COVID-19）的发展]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024 Sep;40(9):839-843.
9
Elevated Exhaustion Levels of NK and CD8 T Cells as Indicators for Progression and Prognosis of COVID-19 Disease.NK 和 CD8 T 细胞衰竭水平升高可作为 COVID-19 疾病进展和预后的指标。
Front Immunol. 2020 Oct 14;11:580237. doi: 10.3389/fimmu.2020.580237. eCollection 2020.
10
Comparison of T Lymphocyte Subsets and Natural Killer Lymphocytes in Moderate Versus Severe COVID-19 Patients.中度与重度新冠肺炎患者T淋巴细胞亚群及自然杀伤淋巴细胞的比较
Viral Immunol. 2023 May;36(4):250-258. doi: 10.1089/vim.2022.0125. Epub 2023 Feb 27.
本文引用的文献
1
NK cell receptor and ligand composition influences the clearance of SARS-CoV-2.自然杀伤细胞受体和配体组成影响 SARS-CoV-2 的清除。
J Clin Invest. 2021 Nov 1;131(21). doi: 10.1172/JCI146408.
2
Rapid induction and persistence of paracrine-induced cellular antiviral states arrest viral infection spread in A549 cells.旁分泌诱导的细胞抗病毒状态的快速诱导和持续存在可阻止病毒感染在A549细胞中的传播。
Virology. 2016 Sep;496:59-66. doi: 10.1016/j.virol.2016.05.019. Epub 2016 May 30.
3
Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses.人巨细胞病毒糖蛋白 UL141 靶向 TRAIL 死亡受体以挫败宿主固有抗病毒防御。
Cell Host Microbe. 2013 Mar 13;13(3):324-35. doi: 10.1016/j.chom.2013.02.003.
4
Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B.腺病毒E3/19K通过将自然杀伤细胞（NK细胞）识别的NKG2D配体主要组织相容性复合体I类链相关蛋白A和B隔离在细胞内，促进对NK细胞识别的逃避。
J Virol. 2008 May;82(9):4585-94. doi: 10.1128/JVI.02251-07. Epub 2008 Feb 20.
5
Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141.人巨细胞病毒UL141对自然杀伤细胞激活配体CD155的下调作用
Nat Immunol. 2005 Feb;6(2):181-8. doi: 10.1038/ni1156. Epub 2005 Jan 9.
Zotero 插件